Spontaneous abortion during ustekinumab therapy
نویسندگان
چکیده
منابع مشابه
Bullous pemphigoid during ustekinumab therapy
BP: Bullous pemphigoid TNF-a: tumor necrosis factor-alfa INTRODUCTION Ustekinumab, a monoclonal antibody that blocks interleukin-12 and interleukin-23, is a biological therapy used to treat moderate-to-severe psoriasis. Bullous pemphigoid (BP) induced by antietumor necrosis factor-alfa (TNF-a) agents has been described in the literature. No cases have been reported with ustekinumab. We report a...
متن کاملWork schedule during pregnancy and spontaneous abortion.
BACKGROUND There is inconsistent evidence as to whether work schedule (including rotating shifts and night work) can affect reproductive outcomes. METHODS We investigated the association between work schedule and risk of spontaneous abortion in U.S. nurses. The Nurses' Health Study II is a prospective cohort study established in 1989. In 2001, information about occupational activities and exp...
متن کاملIntravenous immunoglobulin therapy for recurrent spontaneous abortion: a meta-analysis.
PROBLEM Published randomized trials of the use of intravenous immunoglobulins (IVIG) as a treatment for recurrent spontaneous abortion (RSA) have produced conflicting results. The purpose of this study was to conduct a systematic review of the current evidence to evaluate the effectiveness of IVIG for RSA. METHOD OF STUDY After a thorough search of the literature, four randomized, double-blin...
متن کاملAntidepressants and spontaneous abortion.
On the cover of the July 13, 2010 issue of CMAJ was the heading, “Use of antidepressants in pregnancy increases the risk of spontaneous abortion.” The findings in the related research article by Nakhai-Pour and colleagues are based solely on prescription drugs. No estimate was done of actual compliance with the medications. If a woman was aware that she was pregnant, the likelihood of her takin...
متن کاملParadoxical Flare of Psoriasis after Ustekinumab Therapy
794 Ann Dermatol Received January 12, 2016, Revised September 24, 2016, Accepted for publication October 24, 2016 Corresponding author: Sik Haw, Department of Dermatology, Inje University Ilsan Paik Hospital, 170 Juhwa-ro, Ilsanseo-gu, Goyang 10380, Korea. Tel: 82-31-910-7224, Fax: 82-31-910-7227, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creati...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Dermatological Case Reports
سال: 2012
ISSN: 1898-7249
DOI: 10.3315/jdcr.2012.1116